M&T Bank’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,003
Closed -$412K 1652
2022
Q1
$412K Sell
10,003
-5,204
-34% -$230K ﹤0.01% 1072
2021
Q4
$661K Buy
15,207
+443
+3% +$20K ﹤0.01% 905
2021
Q3
$739K Sell
14,764
-280
-2% -$17K ﹤0.01% 848
2021
Q2
$948K Sell
15,044
-3,723
-20% -$239K ﹤0.01% 776
2021
Q1
$1.74M Buy
18,767
+35
+0.2% +$3.58K 0.01% 593
2020
Q4
$1.68M Buy
18,732
+3,220
+21% +$296K 0.01% 616
2020
Q3
$1.6M Sell
15,512
-3,670
-19% -$396K 0.01% 582
2020
Q2
$1.52M Sell
19,182
-4,739
-20% -$353K 0.01% 582
2020
Q1
$1.38M Buy
23,921
+208
+0.9% +$12K 0.01% 606
2019
Q4
$1.28M Sell
23,713
-2,481
-9% -$135K 0.01% 543
2019
Q3
$1.37M Buy
26,194
+3,325
+15% +$155K 0.01% 619
2019
Q2
$1.1M Sell
22,869
-8,336
-27% -$399K 0.01% 706
2019
Q1
$1.58M Buy
31,205
+651
+2% +$38.4K 0.01% 587
2018
Q4
$1.81M Buy
30,554
+6,323
+26% +$408K 0.01% 517
2018
Q3
$1.59M Sell
24,231
-220
-0.9% -$12.8K 0.01% 606
2018
Q2
$1.23M Sell
24,451
-2,020
-8% -$105K 0.01% 696
2018
Q1
$1.39M Buy
26,471
+3,379
+15% +$168K 0.01% 656
2017
Q4
$1.07M Buy
23,092
+4,350
+23% +$183K 0.01% 744
2017
Q3
$758K Hold
18,742
﹤0.01% 833
2017
Q2
$635K Buy
18,742
+271
+1% +$8.37K ﹤0.01% 898
2017
Q1
$536K Buy
18,471
+1,566
+9% +$47.7K ﹤0.01% 969
2016
Q4
$555K Buy
16,905
+2,903
+21% +$87K ﹤0.01% 1014
2016
Q3
$441K Buy
14,002
+1,987
+17% +$57.7K ﹤0.01% 1104
2016
Q2
$338K Buy
12,015
+3,611
+43% +$142K ﹤0.01% 1187
2016
Q1
$305K Sell
8,404
-8,781
-51% -$310K ﹤0.01% 1263
2015
Q4
$688K Sell
17,185
-1,804
-10% -$62.9K ﹤0.01% 947
2015
Q3
$541K Sell
18,989
-1,681
-8% -$55.4K ﹤0.01% 1031
2015
Q2
$681K Buy
+20,670
New +$641K ﹤0.01% 1050

Other funds holding EBS